Literature DB >> 34006386

Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.

Alexandra C M Van Harten1, Hemali Phatnani2, Serge Przedborski3.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common adult-onset paralytic disorder, characterized mainly by a loss of motor neurons (MNs) in the CNS. Over the past decades, thanks to intense investigations performed in both in vivo and in vitro models of ALS, major progress has been made toward gaining insights into the pathobiology of this incurable, fatal disorder. Among these advances is the growing recognition that non-neuronal cells participate in the degeneration of MNs in ALS, which could transform our understanding of the neurobiology of disease and the ability to devise effective disease-modifying therapies. In this review, we examine the contribution of non-cell-autonomous processes to the pathogenesis of ALS, with a focus on glial cells and in particular on astrocytes.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  amyotrophic lateral sclerosis; astrocytes; microglia; motor neurons; neurodegeneration; neuroinflammation; non-cell autonomous

Mesh:

Year:  2021        PMID: 34006386      PMCID: PMC8972039          DOI: 10.1016/j.tins.2021.04.008

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  92 in total

1.  Necroptosis drives motor neuron death in models of both sporadic and familial ALS.

Authors:  Diane B Re; Virginia Le Verche; Changhao Yu; Mackenzie W Amoroso; Kristin A Politi; Sudarshan Phani; Burcin Ikiz; Lucas Hoffmann; Martijn Koolen; Tetsuya Nagata; Dimitra Papadimitriou; Peter Nagy; Hiroshi Mitsumoto; Shingo Kariya; Hynek Wichterle; Christopher E Henderson; Serge Przedborski
Journal:  Neuron       Date:  2014-02-06       Impact factor: 17.173

2.  Intricate interplay between astrocytes and motor neurons in ALS.

Authors:  Hemali P Phatnani; Paolo Guarnieri; Brad A Friedman; Monica A Carrasco; Michael Muratet; Sean O'Keeffe; Chiamaka Nwakeze; Florencia Pauli-Behn; Kimberly M Newberry; Sarah K Meadows; Juan Carlos Tapia; Richard M Myers; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

3.  Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors.

Authors:  Mary E Hamby; Giovanni Coppola; Yan Ao; Daniel H Geschwind; Baljit S Khakh; Michael V Sofroniew
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

4.  Skeletal muscle is a primary target of SOD1G93A-mediated toxicity.

Authors:  Gabriella Dobrowolny; Michela Aucello; Emanuele Rizzuto; Sara Beccafico; Cristina Mammucari; Simona Boncompagni; Simona Bonconpagni; Silvia Belia; Francesca Wannenes; Carmine Nicoletti; Zaccaria Del Prete; Nadia Rosenthal; Mario Molinaro; Feliciano Protasi; Giorgio Fanò; Marco Sandri; Antonio Musarò
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

5.  Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.

Authors:  Chris Towne; Cédric Raoul; Bernard L Schneider; Patrick Aebischer
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

6.  Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia.

Authors:  Qin Xiao; Weihua Zhao; David R Beers; Albert A Yen; Wenjie Xie; Jenny S Henkel; Stanley H Appel
Journal:  J Neurochem       Date:  2007-06-07       Impact factor: 5.372

7.  The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice.

Authors:  Valeria Gerbino; Esther Kaunga; Junqiang Ye; Daniele Canzio; Sean O'Keeffe; Noam D Rudnick; Paolo Guarnieri; Cathleen M Lutz; Tom Maniatis
Journal:  Neuron       Date:  2020-03-27       Impact factor: 17.173

8.  Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.

Authors:  Christian S Lobsiger; Severine Boillee; Melissa McAlonis-Downes; Amir M Khan; M Laura Feltri; Koji Yamanaka; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

9.  Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia.

Authors:  Oliver H Tam; Nikolay V Rozhkov; Regina Shaw; Duyang Kim; Isabel Hubbard; Samantha Fennessey; Nadia Propp; Delphine Fagegaltier; Brent T Harris; Lyle W Ostrow; Hemali Phatnani; John Ravits; Josh Dubnau; Molly Gale Hammell
Journal:  Cell Rep       Date:  2019-10-29       Impact factor: 9.423

10.  Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow.

Authors:  Vartika Mishra; Diane B Re; Virginia Le Verche; Mariano J Alvarez; Alessandro Vasciaveo; Arnaud Jacquier; Paschalis-Tomas Doulias; Todd M Greco; Monica Nizzardo; Dimitra Papadimitriou; Tetsuya Nagata; Paola Rinchetti; Eduardo J Perez-Torres; Kristin A Politi; Burcin Ikiz; Kevin Clare; Manuel E Than; Stefania Corti; Harry Ischiropoulos; Francesco Lotti; Andrea Califano; Serge Przedborski
Journal:  Nat Commun       Date:  2020-11-04       Impact factor: 14.919

View more
  12 in total

1.  Retromer dysfunction in amyotrophic lateral sclerosis.

Authors:  Eduardo J Pérez-Torres; Irina Utkina-Sosunova; Vartika Mishra; Peter Barbuti; Mariangels De Planell-Saguer; Georgia Dermentzaki; Heather Geiger; Anna O Basile; Nicolas Robine; Delphine Fagegaltier; Kristin A Politi; Paola Rinchetti; Vernice Jackson-Lewis; Matthew Harms; Hemali Phatnani; Francesco Lotti; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-24       Impact factor: 12.779

2.  Early Signs of Neuroinflammation in the Postnatal Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Maria Claudia Gonzalez Deniselle; Alejandro F De Nicola; Maria Meyer; Analia Lima
Journal:  Cell Mol Neurobiol       Date:  2022-10-11       Impact factor: 4.231

3.  Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons.

Authors:  Cristian Arredondo; Carolina Cefaliello; Agnieszka Dyrda; Nur Jury; Pablo Martinez; Iván Díaz; Armando Amaro; Helene Tran; Danna Morales; Maria Pertusa; Lorelei Stoica; Elsa Fritz; Daniela Corvalán; Sebastián Abarzúa; Maxs Méndez-Ruette; Paola Fernández; Fabiola Rojas; Meenakshi Sundaram Kumar; Rodrigo Aguilar; Sandra Almeida; Alexandra Weiss; Fernando J Bustos; Fernando González-Nilo; Carolina Otero; Maria Florencia Tevy; Daryl A Bosco; Juan C Sáez; Thilo Kähne; Fen-Biao Gao; James D Berry; Katharine Nicholson; Miguel Sena-Esteves; Rodolfo Madrid; Diego Varela; Martin Montecino; Robert H Brown; Brigitte van Zundert
Journal:  Neuron       Date:  2022-03-10       Impact factor: 18.688

4.  Neuronal-glial communication perturbations in murine SOD1G93A spinal cord.

Authors:  Michael MacLean; Raquel López-Díez; Carolina Vasquez; Paul F Gugger; Ann Marie Schmidt
Journal:  Commun Biol       Date:  2022-02-28

5.  Microglia Influence Neurofilament Deposition in ALS iPSC-Derived Motor Neurons.

Authors:  Reilly L Allison; Jacob W Adelman; Jenica Abrudan; Raul A Urrutia; Michael T Zimmermann; Angela J Mathison; Allison D Ebert
Journal:  Genes (Basel)       Date:  2022-01-27       Impact factor: 4.096

Review 6.  The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis.

Authors:  Jinmeng Liu; Fenghua Zhou; Yingjun Guan; Fandi Meng; Zhenhan Zhao; Qi Su; Weiwei Bao; Xuemei Wang; Jiantao Zhao; Zijun Huo; Lingyun Zhang; Shuanhu Zhou; Yanchun Chen; Xin Wang
Journal:  Cells       Date:  2022-02-07       Impact factor: 6.600

Review 7.  Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis.

Authors:  Belgin Sever; Halilibrahim Ciftci; Hasan DeMirci; Hilal Sever; Firdevs Ocak; Burak Yulug; Hiroshi Tateishi; Takahisa Tateishi; Masami Otsuka; Mikako Fujita; Ayşe Nazlı Başak
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

Review 8.  Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment.

Authors:  Liaisan Arslanbaeva; Marco Bisaglia
Journal:  Molecules       Date:  2022-02-22       Impact factor: 4.411

Review 9.  Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets.

Authors:  Kazumoto Shibuya; Ryo Otani; Yo-Ichi Suzuki; Satoshi Kuwabara; Matthew C Kiernan
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31

Review 10.  PET imaging of reactive astrocytes in neurological disorders.

Authors:  Yu Liu; Han Jiang; Xiyi Qin; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-07       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.